Neres IL do N, Mello RO, Bernardes JúliaS, Barbosa J de SP. RISK OF CARDIOVASCULAR DISEASE ASSOCIATED WITH THE HALOPERIDOL USE IN PATIENTS WITH SCHIZOPHRENIA. REASE [Internet]. 2026 Aug. 7 [cited 2026 Oct. 13];12(8):1-27. Available from: https://periodicorease.pro.br/rease/article/view/28165